CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Net4CGD is focused on developing a new gene therapy for X-linked chronic granulomatous disease. The project aims to improve the treatment's effectiveness and safety through innovative gene modification techniques.
This project is focused on the clinical development of a new orphan drug that can rapidly become a new treatment option for patients with the X-linked form of chronic granulomatous disease (X-CGD).
This rare primary immune deficiency of phagocytes is caused by mutations in the gp91phox gene.
Affected patients are highly-susceptible to infections and develop inflammatory granulomas.
Several members of the Net4CGD consortium have already attempted hematopoietic gene correction of X-CGD using gp91…
ASSOCIATION GENETHON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
LONDON
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Frankfurt
Type: Research institute
Activity type: Research Organisations
SME: No
UNIVERSITAETSKLINIKUM FRANKFURT
Germany, Frankfurt Am Main
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, ZURICH
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
